Adherence to disease-modifying treatments in patients with multiple sclerosis in Spain
Ramón Morillo Verdugo,1 Esther Ramírez Herráiz,2 Raquel Fernández-Del Olmo,3 Montserrat Roig Bonet,4 María Valdivia García51Valme University Hospital, Seville, Spain; 2La Princesa University Hospital, Madrid, Spain; 3Market Access Dep...
Main Authors: | Morillo Verdugo R, Ramírez Herráiz E, Fernández-Del Olmo R, Roig Bonet M, Valdivia García M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-02-01
|
Series: | Patient Preference and Adherence |
Subjects: | |
Online Access: | https://www.dovepress.com/adherence-to-disease-modifying-treatments-in-patients-with-multiple-sc-peer-reviewed-article-PPA |
Similar Items
-
Mode of administration of dulaglutide: implications for treatment adherence
by: Amblee A
Published: (2016-06-01) -
An evaluation of adherence in patients with multiple sclerosis newly initiating treatment with a self-injectable or an oral disease-modifying drug
by: Munsell M, et al.
Published: (2016-12-01) -
Evaluating Treatment Patterns, Relapses, Healthcare Resource Utilization, and Costs Associated with Disease-Modifying Treatments for Multiple Sclerosis in DMT-Naïve Patients
by: Freeman L, et al.
Published: (2021-01-01) -
Adherence to disease-modifying therapies in patients with multiple sclerosis
by: Kołtuniuk A, et al.
Published: (2018-08-01) -
Using the Medication Adherence Reasons Scale (MAR-Scale) to identify the reasons for non-adherence across multiple disease conditions
by: Unni EJ, et al.
Published: (2019-06-01)